Zymewire

Hey Zymewire Fam! We’ve got something awesome brewing in the Zymewire lab and we’re finally ready to spill the beans… Introducing Zymewire University 🧠🎓 From step-by-step tutorials, exclusive content, and updates on our latest features, Zymewire U has got it all. Enroll now and become a certified Zymewire pro! https://hubs.ly/Q02kJHhH0

Buckle Up 🚀 😎

💸 In 2024, 2,840 biopharma companies raised funding to accelerate their growth. Here are a few notable examples: 1️⃣ AusperBio completed a $73 million Series B financing, led by HanKang Capital, to support Phase 2 development of AHB-137, a potential functional cure for chronic hepatitis B, as well as global clinical trials and commercial-scale manufacturing. 2️⃣ Borealis Biosciences, Inc. secured an additional $30 million in Series A funding, led by Westlake BioPartners, bringing its total to $180 million to advance next-gen RNA therapies for kidney diseases. 3️⃣ SiteOne Therapeutics, Inc. raised $100 million in Series C financing, led by Novo Holdings, to push forward non-opioid treatments for pain and sensory hyperexcitability disorders, including their NaV1.8 sodium channel inhibitor program. We’re getting ready to publish our 2024 Biopharma Recap, and we’d love to hear your thoughts! What insights or data points would you like to see? Let us know in the comments. 👇

🧪 2024 Biopharma in Review: What can we learn from the past year? As 2025 begins, it’s easy to jump straight into new goals and plans. But in biopharma, staying ahead means taking a moment to reflect on the trends, breakthroughs, and challenges of the past year. By understanding where the industry has been, we can uncover where it’s going — and help you better shape your strategy for what’s next. Over the coming days, we’ll be sharing some of the key insights from our upcoming 2024 Biopharma Recap, starting with clinical trial initiations 👇 📊 In 2024, there were 5,791 clinical trial initiations globally. Among them were: 1️⃣ Neurona Therapeutics launched a Phase 1/2 trial for NRTX-1001, a neural cell therapy aimed at treating drug-resistant bilateral mesial temporal lobe epilepsy (MTLE). 2️⃣ Stingray Therapeutics initiated a Phase 2 trial for SR-8541A in combination with botensilimab and balstilimab, targeting refractory metastatic microsatellite stable colorectal cancer (MSS-CRC). 3️⃣ ExpreS2ion Biotechnologies launched a Phase 1 trial for ES2B-C001, a HER2-targeting vaccine for metastatic breast cancer, with the goal of assessing safety, tolerability, and immune response. What matters most to you? As we prepare to release our full recap, we’d love to hear your thoughts. What trends, data points, or insights would be most valuable for you and your team? Drop your suggestions in the comments, and let’s shape this year’s Biopharma Recap together!

What’s worse than bad customer support? Paying a premium for it. 🙅♀️ Legacy databases leave you stranded when you need them most. Your team deserves award-winning support and lightning-fast solutions. #CustomerSupport #SalesTools #FoundItOnZymewire

Conferences are like treasure hunts—if you don’t have a good map, you’ll waste time digging in the wrong spots. 🗺️ Legacy databases leave you wandering, while smarter tools point you to the connections that matter most. #ConferenceStrategy #SalesProspecting #FoundItOnZymewire

Getting loads of data without context is like being handed a map with no directions. 🗺️ Legacy tools drown you in noise when what you need is clarity. Let’s fix that with actionable, contextual insights. #SalesEfficiency #ActionableInsights #FoundItOnZymewire

Data is like milk—when it’s stale, it’s useless (and kind of gross). 🤢 Legacy databases leave you chasing leads that don’t exist anymore. Isn’t it time for a tool that keeps your data fresh and actionable? #DataDrivenSales #SalesIntelligence #FoundItOnZymewire

Imagine needing a full IT team just to get your sales tool to talk to your CRM. 🤦♀️ Legacy databases make it harder than it needs to be. The solution? Seamless integration that works as fast as your team does. #SalesTools #CRMIntegration #FoundItOnZymewire

🤝 A true partnership goes beyond support. At Zymewire, our Customer Success team isn’t just here to troubleshoot—they’re here to transform. When you work with us, you’re paired with a dedicated Customer Success Manager who integrates deeply with your team’s goals, challenges, and strategies. Think of them as an extension of your team, bringing insights and actionable advice that help you refine your approach and boost sales performance. 📈 And the best part? Your CSM won’t rotate out next month or the month after. They’ll be with you for the long haul, helping you grow from day one and beyond. #ClientSuccess #SalesStrategy #BiopharmaSales